Morever, the latest research claimed that the CAR T cells modified by IL-15 can be used as double targeting drugs for tumor cells and myeloid-derived suppressor cells in glioblastoma (Zannikou et al., 2023). The gene discussed is IL15; the disease is neoplasm.